Clonidine Plus GHRH Administration for Diagnosing Growth Hormone Deficiency in Children
Journal Title: Journal of Clinical and Molecular Endocrinology - Year 2017, Vol 2, Issue 1
Abstract
Objective: To analyze the effectiveness and reproductivity of a challenge with clonidine (CLO) plus GHRH administration to establish a state of GH-deficiency and the causes of it. Methods: 24 children (17M, 7F) with stature <1 or 2 SD from P3, previously studied with different classical tests, were given CLO (150 μg/m2 orally, at time 0’) plus GHRH (60’ later, 1 μg/kg, iv). This test was repeated but giving placebo at time 0’. For comparison purposes, 20 agematched normal children (14M, 6F) were studied. Growth velocity (GV) and bone age (BA) before performing CLO +GHRH were considered. Results: While classical GH tests show a great variability of negative or positive GH responses in the same short patient, all but two patients significantly responded to CLO+GHRH (GH peak: 42.2 ± 19 vs. 41.6 ± 3.5 in controls). Controls showed a significant positive correlation between the amplitude of GH response and chronological and bone age (R=0.832; F=37.6; P=0.001, multiple regression analysis): y=a+b × BA+c × CA, where y=GH peak, BA=bone age, CA=chronological age, and a, b and c are constants. This equation allows to establish the value of GH peak theoretically obtained after CLO+GHRH challenge in a normal child. Applying this equation to the responses to CLO+GHRH in short children a deviation, ranging between -435% and +41%, was obtained between theoretical and real GH peaks (%DT-R). Responses between -20% to +20% were considered normal. Plotting these responses (% DT-R) against the SD of the mean of the BA to GV ratio in normal children, five populations were defined: 1) Low response and low GV for BA; 2) Low response and normal GV for BA; 3) Normal response and low GV for BA; 4) Normal response and normal GV for BA; and 5) High response and low GV for BA.
Authors and Affiliations
Jesús Devesa
Keywords
Related Articles
- EP ID EP305797
- DOI 10.21767/2572-5432.100042
- Views 82
- Downloads 0
Antidiabetics and Heart Failure - Large Trials but Little Mechanistic Insight
Glucose lowering efficacy was the basis for the approval of antihyperglycaemic drug in the past. However, increasing concerns emerged about potential cardiovascular side effects of these drugs following the metaanalysis...
Aromatase Inhibitors Combined with Growth Hormone: A Cost-effective Last Chance for Improving Boysâ Stature at the Near-End of Growth?
Two studies have recently shown a clear benefit of using nonsteroidal aromatase inhibitors (AIs) in combination with growth hormone (rhGH) in pubertal boys of very short stature (between -2.5 and - 3 SDS) who are approac...
Might Estrogen Promote Lung Cancer Progression?
In order to understand the differences between sexes in lung cancer presentation and due to the observation that young women have worse prognosis, we studied the participation of estrogens in lung carcinogenesis. We foun...
False Positive TSH Receptor Binding Inhibitory Immunoglobulin in a Patient with Overt Hyperthyroidism Caused by Painless Thyroiditis
The diagnosis of Graves’s disease (GD) can be challenging in patients with atypical presentations of hyperthyroidism. Recently, TSH receptor antibody assays are proposed as first-line test for suspected GD. I here report...
The Other Legacy of Antonie Van Leeuwenhoek: The Polyamines
Antonie van Leeuwenhoek (1632-1723) left us two legacies; the first is the microscope and the second, the discovering of polyamines in the human semen.